215 CHURCH STREET, NEW HAVEN, CT
Investor Presentation
Amendment No. 2 to Equity Distribution Agreement with J.P. Morgan
2026 Annual Meeting Results; Directors Elected Including Michael T. Heffernan
Reports Recent Business Developments and First Quarter 2026 Financial Results
Reports Recent Business Developments and Fourth Quarter and Full Year 2025 Financial Results
Other Events
Biohaven Ltd. Announces $200 Million Public Offering of Common Shares
Q1
FY 2025
Q3
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Prospectus filed pursuant to Rule 424(b)(7)
Confidential Treatment Order